SCHEMBL30920659

SCHEMBL30920659

CC1(C(=O)NCc2cc3cc(C4CC4)c(O)cc3[nH]2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ NPC1 O15118 1/20 0.34
▸ HTT P42858 2/20 0.32
▸ HPGD P15428 1/20 0.32
▸ MTNR1A P48039 1/20 0.31
▸ MTNR1B P49286 1/20 0.31
▸ METTL3 Q86U44 6/20 0.31
▸ METTL14 Q9HCE5 6/20 0.31
▸ IKBKB O14920 1/20 0.31
▸ CA12 O43570 2/20 0.31
▸ CA1 P00915 2/20 0.31
▸ CA2 P00918 2/20 0.31
▸ CA9 Q16790 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ TRPV1 Q8NER1 1/20 0.31
▸ GID4 Q8IVV7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27248077 1.00 RAB9A (0.39) RAB9ASMN1; SMN2NPC1HTTHPGD
SCHEMBL30920404 0.86 MTNR1A (0.40) RAB9ASMN1; SMN2NPC1HPGDMTNR1A
SCHEMBL27247690 0.86 MTNR1A (0.40) RAB9ASMN1; SMN2NPC1HPGDMTNR1A
SCHEMBL27247781 0.83 RAB9A (0.40) RAB9ASMN1; SMN2NPC1HTTHPGD
SCHEMBL30920444 0.82 RAB9A (0.43) RAB9ASMN1; SMN2NPC1METTL3METTL14
SCHEMBL30920136 0.82 RAB9A (0.38) RAB9ASMN1; SMN2NPC1HPGDMTNR1A
SCHEMBL30920251 0.82 SMN1; SMN2 (0.38) RAB9ASMN1; SMN2NPC1METTL3METTL14
SCHEMBL30920406 0.82 SMN1; SMN2 (0.43) RAB9ASMN1; SMN2NPC1HTTMETTL3
SCHEMBL27247588 0.82 RAB9A (0.38) RAB9ASMN1; SMN2NPC1HPGDMTNR1A
SCHEMBL27247646 0.82 SMN1; SMN2 (0.38) RAB9ASMN1; SMN2NPC1METTL3METTL14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4601635-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF Maze Therapeutics, Inc. (US) 2025-08-20 — — EP disclosed
Send feedback